A Phase 1 Trial to Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of MBX-400 in Healthy Volunteers

Trial Profile

A Phase 1 Trial to Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of MBX-400 in Healthy Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Filociclovir (Primary)
  • Indications Cytomegalovirus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Feb 2017 Status changed from recruiting to discontinued as study has met halting criteria after cohort 3 enrollment
    • 02 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 02 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top